| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA877: Finerenone for treating chronic kidney disease in people with type 2 diabetes |
|
Medicine details |
|
| Medicine name | finerenone (Kerendia®) |
| Formulation | 10 mg, 20 mg film coated tablets |
| Reference number | 3110 |
| Indication | Treatment of chronic kidney disease (stage 3 and 4 with albuminuria) associated with type 2 diabetes in adults |
| Company | Bayer Healthcare Pharmaceuticals |
| BNF chapter | Nutrition & blood |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 23/03/2022 |
| NICE guidance | TA877: Finerenone for treating chronic kidney disease in people with type 2 diabetes |